{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:50:23Z","timestamp":1794376223414,"version":"4.9.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"New Round of Xuzhou \"Pengcheng Talent Program\"-High-level Healthcare Talent Recruitment and Development Project","award":["2025QZ004"],"award-info":[{"award-number":["2025QZ004"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170670"],"award-info":[{"award-number":["82170670"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Science and Technology Program of Henan","award":["SB201901045"],"award-info":[{"award-number":["SB201901045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04432-z","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T12:04:35Z","timestamp":1776513875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting FGG alleviates cholestatic fibrosis by inhibiting hepatic stellate cell activation and regulating macrophage homeostasis"],"prefix":"10.1186","volume":"24","author":[{"given":"Qianyi","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"4432_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jhep.2021.02.035","volume":"75","author":"J Li","year":"2021","unstructured":"Li J, et al. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism. J Hepatol. 2021;75:400\u201313. https:\/\/doi.org\/10.1016\/j.jhep.2021.02.035.","journal-title":"J Hepatol"},{"key":"4432_CR2","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41588-024-01687-w","volume":"56","author":"B Wu","year":"2024","unstructured":"Wu B, et al. A spatiotemporal atlas of cholestatic injury and repair in mice. Nat Genet. 2024;56:938\u201352. https:\/\/doi.org\/10.1038\/s41588-024-01687-w.","journal-title":"Nat Genet"},{"key":"4432_CR3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41419-022-05450-z","volume":"13","author":"X Tian","year":"2022","unstructured":"Tian X, et al. Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling. Cell Death Dis. 2022;13:1001. https:\/\/doi.org\/10.1038\/s41419-022-05450-z.","journal-title":"Cell Death Dis"},{"key":"4432_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41419-023-05615-4","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang S, et al. Necroptosis of macrophage is a key pathological feature in biliary atresia via GDCA\/S1PR2\/ZBP1\/p-MLKL axis. Cell Death Dis. 2023;14:175. https:\/\/doi.org\/10.1038\/s41419-023-05615-4.","journal-title":"Cell Death Dis"},{"key":"4432_CR5","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1038\/s41467-025-61442-5","volume":"16","author":"H Ayabe","year":"2025","unstructured":"Ayabe H, et al. Cellular crosstalk mediated by TGF-\u03b2 drives epithelial-mesenchymal transition in patient-derived multi-compartment biliary organoids. Nat Commun. 2025;16:6575. https:\/\/doi.org\/10.1038\/s41467-025-61442-5.","journal-title":"Nat Commun"},{"key":"4432_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jhep.2022.05.044","volume":"77","author":"I Labiano","year":"2022","unstructured":"Labiano I, et al. TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation. J Hepatol. 2022;77:991\u20131004. https:\/\/doi.org\/10.1016\/j.jhep.2022.05.044.","journal-title":"J Hepatol"},{"key":"4432_CR7","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.cgh.2023.02.005","volume":"21","author":"C Levy","year":"2023","unstructured":"Levy C, Manns M, Hirschfield G. New Treatment Paradigms in Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2023;21:2076\u201387. https:\/\/doi.org\/10.1016\/j.cgh.2023.02.005.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4432_CR8","doi-asserted-by":"publisher","first-page":"102404","DOI":"10.1016\/j.redox.2022.102404","volume":"55","author":"M Song","year":"2022","unstructured":"Song M, et al. Inhibition of NLRP3-mediated crosstalk between hepatocytes and liver macrophages by geniposidic acid alleviates cholestatic liver inflammatory injury. Redox Biol. 2022;55:102404. https:\/\/doi.org\/10.1016\/j.redox.2022.102404.","journal-title":"Redox Biol"},{"key":"4432_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00372-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4432_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jhep.2019.04.012","volume":"71","author":"T Nishio","year":"2019","unstructured":"Nishio T, et al. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice. J Hepatol. 2019;71:573\u201385. https:\/\/doi.org\/10.1016\/j.jhep.2019.04.012.","journal-title":"J Hepatol"},{"key":"4432_CR11","doi-asserted-by":"publisher","first-page":"101517","DOI":"10.1016\/j.jhepr.2025.101517","volume":"7","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, et al. Conjugated bile acid-driven CD14(+)CD16(+) monocyte infiltration promotes cholestatic liver injury by enhancing hepatocyte necroptosis. JHEP Rep. 2025;7:101517. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101517.","journal-title":"JHEP Rep"},{"key":"4432_CR12","doi-asserted-by":"publisher","unstructured":"Guthrie G, Vonderohe C, Mel\u00e9ndez Hebib V, Stoll B, Burrin D. Multicomponent parenteral lipid emulsions do not prevent liver injury in neonatal pigs with obstructive cholestasis. JCI Insight. 2025;10. https:\/\/doi.org\/10.1172\/jci.insight.189196.","DOI":"10.1172\/jci.insight.189196"},{"key":"4432_CR13","doi-asserted-by":"publisher","first-page":"e2122310119","DOI":"10.1073\/pnas.2122310119","volume":"119","author":"L Kaps","year":"2022","unstructured":"Kaps L, et al. pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages. Proc Natl Acad Sci U S A. 2022;119:e2122310119. https:\/\/doi.org\/10.1073\/pnas.2122310119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4432_CR14","doi-asserted-by":"publisher","first-page":"155016","DOI":"10.1016\/j.phymed.2023.155016","volume":"119","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Corilagin alleviates liver fibrosis in zebrafish and mice by repressing IDO1-mediated M2 macrophage repolarization. Phytomedicine. 2023;119:155016. https:\/\/doi.org\/10.1016\/j.phymed.2023.155016.","journal-title":"Phytomedicine"},{"key":"4432_CR15","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/hep.0000000000001003","volume":"81","author":"L Zhang","year":"2025","unstructured":"Zhang L, et al. Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation. Hepatology. 2025;81:774\u201390. https:\/\/doi.org\/10.1097\/hep.0000000000001003.","journal-title":"Hepatology"},{"key":"4432_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41419-022-04802-z","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization. Cell Death Dis. 2022;13:411. https:\/\/doi.org\/10.1038\/s41419-022-04802-z.","journal-title":"Cell Death Dis"},{"key":"4432_CR17","doi-asserted-by":"publisher","unstructured":"Zhang K, et al. Targeting GPR65 alleviates hepatic inflammation and fibrosis by suppressing the JNK and NF-\u03baB pathways. Mil Med Res. 2023;10. https:\/\/doi.org\/10.1186\/s40779-023-00494-4.","DOI":"10.1186\/s40779-023-00494-4"},{"key":"4432_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.7150\/ijbs.99345","volume":"21","author":"Y Xu","year":"2025","unstructured":"Xu Y, et al. USP25 stabilizes STAT6 to promote IL-4-induced macrophage M2 polarization and fibrosis. Int J Biol Sci. 2025;21:475\u201389. https:\/\/doi.org\/10.7150\/ijbs.99345.","journal-title":"Int J Biol Sci"},{"key":"4432_CR19","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/01.pas.0000209848.59670.2c","volume":"30","author":"L Rubbia-Brandt","year":"2006","unstructured":"Rubbia-Brandt L, Neerman-Arbez M, Rougemont AL, Mal\u00e9 PJ, Spahr L. Fibrinogen gamma375 arg\u2013>trp mutation (fibrinogen aguadilla) causes hereditary hypofibrinogenemia, hepatic endoplasmic reticulum storage disease and cirrhosis. Am J Surg Pathol. 2006;30:906\u201311. https:\/\/doi.org\/10.1097\/01.pas.0000209848.59670.2c.","journal-title":"Am J Surg Pathol"},{"key":"4432_CR20","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1016\/j.jtha.2023.04.003","volume":"21","author":"LG Poole","year":"2023","unstructured":"Poole LG, et al. Altered fibrinogen \u03b3-chain cross-linking in mutant fibrinogen-\u03b3(\u22065) mice drives acute liver injury. J Thromb Haemost. 2023;21:2175\u201388. https:\/\/doi.org\/10.1016\/j.jtha.2023.04.003.","journal-title":"J Thromb Haemost"},{"key":"4432_CR21","doi-asserted-by":"publisher","unstructured":"Han X, et al. Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis. Nat Commun. 2023;14. https:\/\/doi.org\/10.1038\/s41467-022-35637-z.","DOI":"10.1038\/s41467-022-35637-z"},{"key":"4432_CR22","doi-asserted-by":"publisher","first-page":"14852","DOI":"10.1021\/acsnano.3c03217","volume":"17","author":"C Zhang","year":"2023","unstructured":"Zhang C, et al. Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells. ACS Nano. 2023;17:14852\u201370. https:\/\/doi.org\/10.1021\/acsnano.3c03217.","journal-title":"ACS Nano"},{"key":"4432_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.biochi.2020.08.013","volume":"177","author":"A Uzzaman","year":"2020","unstructured":"Uzzaman A, et al. Discovery of small extracellular vesicle proteins from human serum for liver cirrhosis and liver cancer. Biochimie. 2020;177:132\u201341. https:\/\/doi.org\/10.1016\/j.biochi.2020.08.013.","journal-title":"Biochimie"},{"key":"4432_CR24","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1021\/acs.jproteome.9b00563","volume":"19","author":"JS Wu","year":"2020","unstructured":"Wu JS, et al. Quantitative Proteomics Reveals the Protective Effects of Huangqi Decoction Against Acute Cholestatic Liver Injury by Inhibiting the NF-\u03baB\/IL-6\/STAT3 Signaling Pathway. J Proteome Res. 2020;19:677\u201387. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00563.","journal-title":"J Proteome Res"},{"key":"4432_CR25","doi-asserted-by":"publisher","unstructured":"Bai YM, et al. Single-cell transcriptomic dissection of the cellular and molecular events underlying the triclosan-induced liver fibrosis in mice. Mil Med Res. 2023;10. https:\/\/doi.org\/10.1186\/s40779-023-00441-3.","DOI":"10.1186\/s40779-023-00441-3"},{"key":"4432_CR26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12951-024-02888-5","volume":"22","author":"Z Xue","year":"2024","unstructured":"Xue Z, et al. Hypoxic glioma-derived exosomal miR-25-3p promotes macrophage M2 polarization by activating the PI3K-AKT-mTOR signaling pathway. J Nanobiotechnol. 2024;22:628. https:\/\/doi.org\/10.1186\/s12951-024-02888-5.","journal-title":"J Nanobiotechnol"},{"key":"4432_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13045-020-00991-2","volume":"13","author":"S Zhao","year":"2020","unstructured":"Zhao S, et al. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer. J Hematol Oncol. 2020;13:156. https:\/\/doi.org\/10.1186\/s13045-020-00991-2.","journal-title":"J Hematol Oncol"},{"key":"4432_CR28","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.2147\/jir.S423819","volume":"16","author":"K Hu","year":"2023","unstructured":"Hu K, Shang Z, Yang X, Zhang Y, Cao L. Macrophage Polarization and the Regulation of Bone Immunity in Bone Homeostasis. J Inflamm Res. 2023;16:3563\u201380. https:\/\/doi.org\/10.2147\/jir.S423819.","journal-title":"J Inflamm Res"},{"key":"4432_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","volume":"79","author":"PJ Murray","year":"2017","unstructured":"Murray PJ. Macrophage Polarization. Annu Rev Physiol. 2017;79:541\u201366. https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034339.","journal-title":"Annu Rev Physiol"},{"key":"4432_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41467-024-55738-1","volume":"16","author":"LX Yang","year":"2025","unstructured":"Yang LX, et al. Alleviation of liver fibrosis by inhibiting a non-canonical ATF4-regulated enhancer program in hepatic stellate cells. Nat Commun. 2025;16:524. https:\/\/doi.org\/10.1038\/s41467-024-55738-1.","journal-title":"Nat Commun"},{"key":"4432_CR31","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41418-020-00650-6","volume":"28","author":"LZ Rao","year":"2021","unstructured":"Rao LZ, et al. IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages. Cell Death Differ. 2021;28:1270\u201383. https:\/\/doi.org\/10.1038\/s41418-020-00650-6.","journal-title":"Cell Death Differ"},{"key":"4432_CR32","doi-asserted-by":"publisher","first-page":"22508","DOI":"10.1021\/acsnano.3c05998","volume":"17","author":"L Luo","year":"2023","unstructured":"Luo L, et al. Precisely Regulating M2 Subtype Macrophages for Renal Fibrosis Resolution. ACS Nano. 2023;17:22508\u201326. https:\/\/doi.org\/10.1021\/acsnano.3c05998.","journal-title":"ACS Nano"},{"key":"4432_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cmet.2022.02.002","volume":"34","author":"MC Runtsch","year":"2022","unstructured":"Runtsch MC, et al. Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages. Cell Metab. 2022;34:487\u2013e501488. https:\/\/doi.org\/10.1016\/j.cmet.2022.02.002.","journal-title":"Cell Metab"},{"key":"4432_CR34","doi-asserted-by":"publisher","first-page":"e2408898","DOI":"10.1002\/advs.202408898","volume":"12","author":"LF Zhang","year":"2025","unstructured":"Zhang LF, et al. Pathological Microenvironment-Remodeling Nanoparticles to Alleviate Liver Fibrosis: Reversing Hepatocytes-Hepatic Stellate Cells Malignant Crosstalk. Adv Sci (Weinh). 2025;12:e2408898. https:\/\/doi.org\/10.1002\/advs.202408898.","journal-title":"Adv Sci (Weinh)"},{"key":"4432_CR35","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/hep.27936","volume":"62","author":"C Jim\u00e9nez Calvente","year":"2015","unstructured":"Jim\u00e9nez Calvente C, et al. Specific hepatic delivery of procollagen \u03b11(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosis. Hepatology. 2015;62:1285\u201397. https:\/\/doi.org\/10.1002\/hep.27936.","journal-title":"Hepatology"},{"key":"4432_CR36","doi-asserted-by":"publisher","first-page":"101436","DOI":"10.1016\/j.omtm.2025.101436","volume":"33","author":"M Hosseini-Kharat","year":"2025","unstructured":"Hosseini-Kharat M, Bremmell KE, Prestidge CA. Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism. Mol Ther Methods Clin Dev. 2025;33:101436. https:\/\/doi.org\/10.1016\/j.omtm.2025.101436.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4432_CR37","doi-asserted-by":"publisher","first-page":"14397","DOI":"10.1002\/anie.201408221","volume":"53","author":"OF Khan","year":"2014","unstructured":"Khan OF, et al. Ionizable amphiphilic dendrimer-based nanomaterials with alkyl-chain-substituted amines for tunable siRNA delivery to the liver endothelium in vivo. Angew Chem Int Ed Engl. 2014;53:14397\u2013401. https:\/\/doi.org\/10.1002\/anie.201408221.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4432_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/hep.0000000000000317","volume":"78","author":"J Zhang","year":"2023","unstructured":"Zhang J, et al. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases. Hepatology. 2023;78:10\u201325. https:\/\/doi.org\/10.1097\/hep.0000000000000317.","journal-title":"Hepatology"},{"key":"4432_CR39","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/hep.31987","volume":"74","author":"W Yang","year":"2021","unstructured":"Yang W, et al. Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice. Hepatology. 2021;74:2774\u201390. https:\/\/doi.org\/10.1002\/hep.31987.","journal-title":"Hepatology"},{"key":"4432_CR40","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.cmet.2024.04.003","volume":"36","author":"R Isaac","year":"2024","unstructured":"Isaac R, et al. TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosis. Cell Metab. 2024;36:1030\u2013e10431037. https:\/\/doi.org\/10.1016\/j.cmet.2024.04.003.","journal-title":"Cell Metab"},{"key":"4432_CR41","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.immuni.2021.04.021","volume":"54","author":"MB Buechler","year":"2021","unstructured":"Buechler MB, Fu W, Turley SJ. Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer. Immunity. 2021;54:903\u201315. https:\/\/doi.org\/10.1016\/j.immuni.2021.04.021.","journal-title":"Immunity"},{"key":"4432_CR42","doi-asserted-by":"publisher","first-page":"113873","DOI":"10.1016\/j.intimp.2024.113873","volume":"146","author":"S Shen","year":"2025","unstructured":"Shen S, et al. Macrophage-to-myofibroblast transition and its role in cardiac fibrosis. Int Immunopharmacol. 2025;146:113873. https:\/\/doi.org\/10.1016\/j.intimp.2024.113873.","journal-title":"Int Immunopharmacol"},{"key":"4432_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","volume":"15","author":"PM Tang","year":"2019","unstructured":"Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15:144\u201358. https:\/\/doi.org\/10.1038\/s41581-019-0110-2.","journal-title":"Nat Rev Nephrol"},{"key":"4432_CR44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41420-021-00756-x","volume":"7","author":"B Shu","year":"2021","unstructured":"Shu B, et al. The METTL3\/MALAT1\/PTBP1\/USP8\/TAK1 axis promotes pyroptosis and M1 polarization of macrophages and contributes to liver fibrosis. Cell Death Discov. 2021;7:368. https:\/\/doi.org\/10.1038\/s41420-021-00756-x.","journal-title":"Cell Death Discov"},{"key":"4432_CR45","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2017.05.022","volume":"67","author":"PF Ma","year":"2017","unstructured":"Ma PF, et al. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice. J Hepatol. 2017;67:770\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2017.05.022.","journal-title":"J Hepatol"},{"key":"4432_CR46","doi-asserted-by":"publisher","unstructured":"Wang Y, et al. MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program. Sci Adv. 2021;7. https:\/\/doi.org\/10.1126\/sciadv.abb6075.","DOI":"10.1126\/sciadv.abb6075"},{"key":"4432_CR47","doi-asserted-by":"publisher","first-page":"155687","DOI":"10.1016\/j.phymed.2024.155687","volume":"130","author":"L Deng","year":"2024","unstructured":"Deng L, et al. Icariside II modulates pulmonary fibrosis via PI3K\/Akt\/\u03b2-catenin pathway inhibition of M2 macrophage program. Phytomedicine. 2024;130:155687. https:\/\/doi.org\/10.1016\/j.phymed.2024.155687.","journal-title":"Phytomedicine"},{"key":"4432_CR48","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis. Nat Rev Gastroenterol Hepatol. 2023;20:633\u201346. https:\/\/doi.org\/10.1038\/s41575-023-00807-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4432_CR49","doi-asserted-by":"publisher","first-page":"7940","DOI":"10.7150\/thno.109442","volume":"15","author":"T Wu","year":"2025","unstructured":"Wu T, et al. Targeting the self-amplifying loop between ATF6 and SNAI1 to inhibit epithelial\u2013mesenchymal transition in fibrotic lesions. Theranostics. 2025;15:7940\u201355. https:\/\/doi.org\/10.7150\/thno.109442.","journal-title":"Theranostics"},{"key":"4432_CR50","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1097\/hep.0000000000000762","volume":"81","author":"Y Xia","year":"2025","unstructured":"Xia Y, et al. Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC. Hepatology. 2025;81:947\u201361. https:\/\/doi.org\/10.1097\/hep.0000000000000762.","journal-title":"Hepatology"},{"key":"4432_CR51","doi-asserted-by":"publisher","first-page":"101935","DOI":"10.1016\/j.xcrm.2025.101935","volume":"6","author":"H Yang","year":"2025","unstructured":"Yang H, et al. Integrative proteo-transcriptomic characterization of advanced fibrosis in chronic liver disease across etiologies. Cell Rep Med. 2025;6:101935. https:\/\/doi.org\/10.1016\/j.xcrm.2025.101935.","journal-title":"Cell Rep Med"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04432-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04432-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04432-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:55:03Z","timestamp":1780390503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04432-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4432"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04432-z","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving animals were reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University, China (2021-KY-0990-02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"525"}}